Human cold pain: a randomized crossover trial
Assessed by RV014 · Research Fellow
Assessed on 5 Nov 2025
OverallReviewer's overall integrity assessment, derived from all research questions No concerns
DOI 10.1097/j.pain.0000000000003503 (opens in new tab)
Resource ripekg:research-integrity-assessment/RIPEA00C7F305EF5555AE
5 Research Questions · 2 Evidence Items
Q1.1 — Does the study have an associated retraction?
Rationale: I agree with INSPECT-AI
Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?
Rationale: I agree with INSPECT-AI
Q1.3 — Do other studies by the research team highlight causes for concern?
Rationale: I agree with INSPECT-AI
Q2.2 — Are there concerns relating to the timing or absence of study registration?
Rationale: I agree with INSPECT-AI
Supporting Evidence (2)
Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)
Registration ID: NCT05935280
Registry: ClinicalTrials.gov
Registry Link: https://clinicaltrials.gov/study/NCT05935280 (opens in new tab)
Registration Date: 06-07-2023
Prospective:Whether the trial was registered before participant recruitment began Yes
Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registration date is on or before LLM recruitment start date.
Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text
Recruitment Start: 07-07-2023
Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Results: 'The first participant was included on July 7, 2023'.
Recruitment End: 01-09-2023
Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date Results: 'and the 36th participant on September 1, 2023'.
Study End: 01-09-2023
Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date Results: 'The trial ended when the target sample size of 36 was reached' which was on 01-09-2023.
Overall — What is the overall integrity assessment of the study?
Rationale: No integrity concerns based on these checks